Pip Patrick

1.7k total citations
26 papers, 614 citations indexed

About

Pip Patrick is a scholar working on Pathology and Forensic Medicine, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Pip Patrick has authored 26 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 10 papers in Oncology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Pip Patrick's work include Lymphoma Diagnosis and Treatment (12 papers), Acute Lymphoblastic Leukemia research (10 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Pip Patrick is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Acute Lymphoblastic Leukemia research (10 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Pip Patrick collaborates with scholars based in United Kingdom, United States and Australia. Pip Patrick's co-authors include Amy A. Kirkwood, Lindsey Stevens, Clare Rowntree, Laura Clifton‐Hadley, Lisa Lowry, John Davies, David C. Linch, June Warden, David Cunningham and Fiona Miall and has published in prestigious journals such as Blood, The Journal of Immunology and The Lancet Oncology.

In The Last Decade

Pip Patrick

24 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pip Patrick United Kingdom	11	340	275	213	113	108	26	614
J.P. Vannier France	10	264 0.8×	185 0.7×	106 0.5×	109 1.0×	76 0.7×	26	659
Santiago Mercadal Spain	12	567 1.7×	403 1.5×	66 0.3×	235 2.1×	69 0.6×	56	710
Irene Della Starza Italy	13	233 0.7×	144 0.5×	169 0.8×	203 1.8×	178 1.6×	41	480
Finlay MacDougall United Kingdom	7	374 1.1×	352 1.3×	71 0.3×	166 1.5×	98 0.9×	13	680
Kenneth Offit United States	11	663 1.9×	453 1.6×	63 0.3×	334 3.0×	43 0.4×	14	1.2k
Wolf‐Dieter Ludwig Germany	15	424 1.2×	276 1.0×	455 2.1×	157 1.4×	481 4.5×	25	1.0k
Sarah A. Bannon United States	14	303 0.9×	285 1.0×	93 0.4×	119 1.1×	263 2.4×	33	743
Karin E. Summers United Kingdom	9	404 1.2×	280 1.0×	98 0.5×	251 2.2×	163 1.5×	11	608
O. Pate United States	9	380 1.1×	280 1.0×	76 0.4×	284 2.5×	71 0.7×	13	581
Valérie Bonadona France	12	245 0.7×	460 1.7×	55 0.3×	60 0.5×	43 0.4×	38	1.0k

Countries citing papers authored by Pip Patrick

Since Specialization

Citations

This map shows the geographic impact of Pip Patrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pip Patrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pip Patrick more than expected).

Fields of papers citing papers by Pip Patrick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pip Patrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pip Patrick. The network helps show where Pip Patrick may publish in the future.

Co-authorship network of co-authors of Pip Patrick

This figure shows the co-authorship network connecting the top 25 collaborators of Pip Patrick. A scholar is included among the top collaborators of Pip Patrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pip Patrick. Pip Patrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marzolini, Maria A. V., Wendi Qian, Laura Clifton‐Hadley, et al.. (2024). Quality of life in advanced‐stage, asymptomatic, non‐bulky follicular lymphoma treated with rituximab shows significant improvement compared with watchful‐waiting. British Journal of Haematology. 206(3). 876–886. 2 indexed citations

Patel, Bela, Amy A. Kirkwood, Clare Rowntree, et al.. (2024). Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia. HemaSphere. 8(6). e88–e88.

Moorman, Anthony V., Eleanor J. Ward, Amy A. Kirkwood, et al.. (2021). Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study. Leukemia. 36(3). 625–636. 36 indexed citations

Creasey, Thomas, Sarra Ryan, Amy A. Kirkwood, et al.. (2021). Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials. Haematologica. 107(9). 2051–2063. 14 indexed citations

Rowntree, Clare, Amy A. Kirkwood, Laura Clifton‐Hadley, et al.. (2021). First Analysis of the UKALL14 Randomized Trial to Determine Whether the Addition of Nelarabine to Standard Chemotherapy Improves Event Free Survival in Adults with T-Cell Acute Lymphoblastic Leukaemia (CRUK/09/006). Blood. 138(Supplement 1). 366–366. 16 indexed citations

Marks, David I., Amy A. Kirkwood, Clare Rowntree, et al.. (2019). First Analysis of the UKALL14 Phase 3 Randomised Trial to Determine If the Addition of Rituximab to Standard Induction Chemotherapy Improves EFS in Adults with Precursor B-ALL (CRUK/09/006). Blood. 134(Supplement_1). 739–739. 10 indexed citations

Creasey, Thomas, Amy A. Kirkwood, Claire Schwab, et al.. (2019). Genetic and Genomic Characterisation of Older Adults with Acute Lymphoblastic Leukemia Treated on the UKALL14 and UKALL60+ Clinical Trials. Blood. 134(Supplement_1). 2746–2746. 1 indexed citations

Moorman, Anthony V., Amy A. Kirkwood, Claire Schwab, et al.. (2019). Prognostic Impact of Chromosomal Abnormalities and Copy Number Alterations Among Adults with B-Cell Precursor Acute Lymphoblastic Leukaemia Treated on UKALL14. Blood. 134(Supplement_1). 288–288. 4 indexed citations

Anderson, Richard A., Amy A. Kirkwood, Pip Patrick, et al.. (2018). Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial. The Lancet Oncology. 19(10). 1328–1337. 52 indexed citations

10.

Rule, Simon, Gordon Cook, Nigel H. Russell, et al.. (2018). Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma. British Journal of Haematology. 184(6). 999–1005. 25 indexed citations

11.

Pike, Lucy, Amy A. Kirkwood, Pip Patrick, et al.. (2017). CAN BASELINE PET‐CT FEATURES PREDICT OUTCOMES IN ADVANCED HODGKIN LYMPHOMA? A PROSPECTIVE EVALUATION OF UK PATIENTS IN THE RATHL TRIAL (CRUK/07/033). Hematological Oncology. 35(S2). 37–38. 17 indexed citations

12.

Kirkwood, Amy A., Massimo Federico, Judith Trotman, et al.. (2017). OUTCOMES OF TREATMENT FOR OBESE PATIENTS WITH ADVANCED HODGKIN LYMPHOMA IN THE RATHL TRIAL (CRUK/07/033). Hematological Oncology. 35(S2). 172–172.

13.

Trotman, Judith, Alexander Fosså, Massimo Federico, et al.. (2017). RESPONSE‐ADJUSTED THERAPY FOR ADVANCED HODGKIN LYMPHOMA (RATHL) TRIAL: LONGER FOLLOW UP CONFIRMS EFFICACY OF DE‐ESCALATION AFTER a NEGATIVE INTERIM PET SCAN (CRUK/07/033).. Hematological Oncology. 35(S2). 65–67. 19 indexed citations

14.

Peggs, K, Gary Cook, NH Russell, et al.. (2016). Reduced intensity conditioned allogeneic stem cell transplantation (RIC-Allo) as front-line therapy for mantle cell lymphoma (MCL): Results from the UK Phase II Mini Allo Study (CRUK: C7627/A9080). UCL Discovery (University College London). 2 indexed citations

15.

Patel, Bijendra, Amy A. Kirkwood, Aditi Dey, et al.. (2016). Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial. Leukemia. 31(1). 58–64. 88 indexed citations

16.

Ardeshna, Kirit M., Wendi Qian, Paul Smith, et al.. (2014). Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial. The Lancet Oncology. 15(4). 424–435. 248 indexed citations

17.

Patrick, Pip. (2014). The ‘Obese Medieval Monk’: A multidisciplinary study of a stereotype. University of Michigan Press eBooks. 6 indexed citations

18.

Illidge, Tim, Clara C. Chan, Nicholas Counsell, et al.. (2013). Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma. British Journal of Cancer. 109(10). 2566–2573. 27 indexed citations

19.

Hough, Rachael, Bronwen E. Shaw, Pip Patrick, et al.. (2013). Early Multilineage Chimerism Predicts The ‘Winning’ Unit In Double Cord Blood Transplantation. Blood. 122(21). 300–300. 1 indexed citations

20.

Khoo, Poh‐Lynn, et al.. (2008). Cell Grafting and Labeling in Postimplantation Mouse Embryos. Methods in molecular biology. 461. 47–70. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact